Delcath Systems (NASDAQ:DCTH - Get Free Report)'s stock had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.
Other analysts also recently issued reports about the stock. Wall Street Zen upgraded shares of Delcath Systems from a "hold" rating to a "buy" rating in a research report on Saturday. Stephens restated an "overweight" rating and issued a $25.00 price target on shares of Delcath Systems in a report on Monday, June 23rd. Finally, HC Wainwright lifted their price objective on shares of Delcath Systems from $29.00 to $31.00 and gave the stock a "buy" rating in a research report on Thursday, August 7th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $24.50.
Read Our Latest Stock Analysis on Delcath Systems
Delcath Systems Stock Performance
Shares of NASDAQ DCTH traded up $0.30 during midday trading on Wednesday, hitting $11.10. 503,861 shares of the company traded hands, compared to its average volume of 691,297. The firm has a market cap of $388.28 million, a P/E ratio of 222.00 and a beta of 0.84. Delcath Systems has a 12-month low of $8.08 and a 12-month high of $18.23. The stock has a 50-day moving average price of $10.90 and a 200 day moving average price of $12.50.
Delcath Systems (NASDAQ:DCTH - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.05. Delcath Systems had a net margin of 3.18% and a return on equity of 6.91%. The business had revenue of $24.16 million for the quarter, compared to analysts' expectations of $22.84 million. As a group, equities analysts expect that Delcath Systems will post -0.79 earnings per share for the current year.
Institutional Investors Weigh In On Delcath Systems
Several institutional investors have recently made changes to their positions in the stock. Bank of America Corp DE raised its stake in Delcath Systems by 1,816.5% in the 4th quarter. Bank of America Corp DE now owns 25,700 shares of the company's stock valued at $309,000 after purchasing an additional 24,359 shares during the last quarter. Inlight Wealth Management LLC purchased a new position in shares of Delcath Systems during the 1st quarter valued at approximately $85,000. Capital Advisors Wealth Management LLC purchased a new position in shares of Delcath Systems during the 1st quarter valued at approximately $891,000. Cannon Global Investment Management LLC bought a new position in Delcath Systems during the first quarter worth $239,000. Finally, Principal Financial Group Inc. lifted its stake in Delcath Systems by 2.1% during the first quarter. Principal Financial Group Inc. now owns 117,620 shares of the company's stock worth $1,497,000 after purchasing an additional 2,437 shares during the last quarter. 61.12% of the stock is currently owned by hedge funds and other institutional investors.
About Delcath Systems
(
Get Free Report)
Delcath Systems, Inc, an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Delcath Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delcath Systems wasn't on the list.
While Delcath Systems currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.